Success Metrics

Clinical Success Rate
85.7%

Based on 42 completed trials

Completion Rate
86%(42/49)
Active Trials
8(11%)
Results Posted
17%(7 trials)
Terminated
7(10%)

Phase Distribution

Ph phase_4
16
23%
Ph not_applicable
11
15%
Ph phase_1
6
8%
Ph phase_2
14
20%
Ph phase_3
24
34%

Phase Distribution

6

Early Stage

14

Mid Stage

40

Late Stage

Phase Distribution71 total trials
Phase 1Safety & dosage
6(8.5%)
Phase 2Efficacy & side effects
14(19.7%)
Phase 3Large-scale testing
24(33.8%)
Phase 4Post-market surveillance
16(22.5%)
N/ANon-phased studies
11(15.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.0%

42 of 50 finished

Non-Completion Rate

16.0%

8 ended early

Currently Active

8

trials recruiting

Total Trials

71

all time

Status Distribution
Active(11)
Completed(42)
Terminated(8)
Other(10)

Detailed Status

Completed42
unknown10
Terminated7
Recruiting6
Not yet recruiting3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
71
Active
8
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (8.5%)
Phase 214 (19.7%)
Phase 324 (33.8%)
Phase 416 (22.5%)
N/A11 (15.5%)

Trials by Status

not_yet_recruiting34%
recruiting68%
active_not_recruiting23%
completed4259%
terminated710%
unknown1014%
withdrawn11%

Recent Activity

Clinical Trials (71)

Showing 20 of 71 trialsScroll for more
NCT05032508Phase 4

Efficacy of the Application of Xylocaine Impregnated Compress in Reducing Per-procedural Pain During Ultrasound-guided Infiltration of Trigger Finger

Completed
NCT07478003Phase 3

Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial

Recruiting
NCT05145283Phase 2

Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation

Completed
NCT06464146Phase 3

Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine

Recruiting
NCT04459117Phase 2

Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen

Completed
NCT07180953Phase 4

Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty

Recruiting
NCT05220319Phase 4

CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients

Completed
NCT02739295Phase 4

G-CSF in the Treatment of Toxic Epidermal Necrolysis

Completed
NCT07278661Phase 2

Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.

Not Yet Recruiting
NCT00620490Phase 3

Paravertebral Analgesia Associated With Intravenous Morphine PCA After Thoracotomy

Completed
NCT07133048Not Applicable

Evaluation of Regional Blocks Efficacy in Orthognathic Surgery

Completed
NCT03700138Phase 3

Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies

Completed
NCT05350592Phase 2

Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock

Active Not Recruiting
NCT06993740Not Applicable

Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

Recruiting
NCT06419075Phase 4

Tranexamic Acid in Vaginal Reconstructive Surgery

Withdrawn
NCT05117034Not Applicable

Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.

Active Not Recruiting
NCT06595680Phase 2

Development of an Innovative Hemodialysis Method to Improve Dialytic Clearance of Protein-bound Uremic Toxins

Not Yet Recruiting
NCT05120076Phase 3

Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy

Recruiting
NCT06398275Phase 2

Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty

Unknown
NCT06349798Phase 3

Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO)

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
71